Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FEMASYS INCFEMY · Entity 7510 | Chief Commercial Officer | February 12, 2024 | February 14, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FEMASYS INC
Report date February 12, 2024 · Filed February 14, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.10 · Expires 2034-02-12 | Direct | 100,000 |
Reported balance
After 2024-02-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-02-12 · Grant · Acquired 100,000 · Balance 100,000 F1: The shares underlying the stock option vest equally in installments over 4 years beginning on February 12, 2024, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying the stock option vest equally in installments over 4 years beginning on February 12, 2024, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2024 Filed Feb 14, 2024 02:47 UTC | FEMASYS INC FEMY · Entity 7510 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001140361-24-007609 · form4.xml · derivative · entry 1 Spector Richard D. · CIK 0002010688 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-02-12 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on February 12, 2024, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.